Skip to main content

Table 2 PSMA-PET characteristics of 13 included studies

From: Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis

Author, publication year

Ligand

Scanner vendor/model

Mean dose (MBq)

Uptake time (min)

Acquisition time (min/bed)

Furosemide

Criteria for SVI or EPE

Blinded reading

Anatomical imaging

MRI details

Contrast-enhanced CT

Agrawal A, 2017

68Ga-PSMA-11

NR/NR

NR

NR

NR

NR

None

NR

CT

 

NR

Berger I, 2018

68Ga-PSMA-11

Philips/Gemini TF 64

NR

NR

1 h in total

NR

None

Yes

CT

 

NR

Dekalo S, 2019

68Ga-PSMA-11

GE/Discovery 690

NR (148-166.5)

45-60

4

NR

None

Yes

CT

 

No

Fendler WP, 2016

68Ga-PSMA-11

Siemens/Biograph 64 TruePoint and GE/Discovery 690

*192 ± 48 (104-276)

*58 ± 12 (45-80)

NR

Yes

None

Yes

CT

 

Yes

Gao J, 2019

68Ga-PSMA-11

United Imaging/uMI 780

131.72 (130.6-177.6)

45

3

NR

None

No

CT

 

No

Grubmuller B, 2018

68Ga-PSMA-11

Siemens/Biograph mMR

2/kg body weight

45

4

Yes

EPE: T2WI assessment in PSMA-positive lesion

SVI: PSMA focus present in parts of seminal vesicles

Yes

MRI

3 T, mp

 

Gupta M, 2018

68Ga-PSMA-11

Siemens/Biograph TruePoint40

2/kg body weight

NR

4

NR

EPE: irregular prostate outline or extraprostatic structure involvement

SVI: increased uptake in seminal vesicles.

Yes

CT

 

NR

Muehlematter UJ, 2019

68Ga-PSMA-11

GE/SIGNA

*131 ± 18.8 (98-158)

60

15, prostate

2-3, rest of body

Yes

MRI findings + abnormal uptake outside prostate or in seminal vesicle

Yes

MRI

cMostly 3 T, bp

 

Thalgot M, 2018

68Ga-PSMA-11

Siemens/Biograph mMR

138 (IQR, 114-156)

55 (IQR, 50-67)

15, prostate

5, rest of body

Yes

EPE = MRI findings

SVI = MRI findings + uptake in seminal vesicle

Yes

MRI

3 T, mp

 

van Leeuwen PJ, 2019

68Ga-PSMA-11

Phillips/Ingenuity and Gemini

a2.0/kg

b100

a60

b45

a3

b2 except for 3 in abdomen/pelvis

NR

None

Yes

CT

 

Yes

von Klot CAJ, 2017

68Ga-PSMA-I&T

Siemens/Biograph mCT

*98 ± 25 (60-130)

60 min

Continuous motion at 0.9 mm/s (chest-abdomen), 2.1 mm/s (leg)

NR

EPE: angulated contour of the prostate gland

SVI: none

Yes

CT

 

No

Yilmaz B, 2019

68Ga-PSMA-11

Siemens/NR

175 (77-350)

60 min

3

NR

EPE: none

SVI: visually as positive or negative

NR

CT

  
  1. BP Biparametric, CT Computed tomography, Ga Gallium, EPE Extraprostatic extension, MP Multi-parametric, MRI Magnetic resonance imaging, NR Not reported; PET Positron emission tomography; PSA Prostate-specific antigen, PSMA Prostate-specific membrane antigen, SVI Seminal vesical invasion
  2. *Data presented in mean ± standard deviation; others are presented in median and ranges
  3. aSt Vincent’s Hospital
  4. bNetherlands Cancer Institute
  5. c3 T performed in 36/40 patients and 1.5 T in 4/40